col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


237 Ergebisse       Seite 1

 [1] 
American Association for the Advancement of Science (AAAS): Science Advances
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2025―Apr―23 Structure-based discovery of highly bioavailable, covalent, broad-spectrum coronavirus M Pro inhibitors with potent in vivo efficacy Tyler C. Detomasi, Gilles Degotte, Sijie Huang, Rahul K. Suryawanshi, Amy Diallo, Luca Lizzadro, et al. (+27)
2 [GO] 2025―Mrz―28 Preemptive optimization of a clinical antibody for broad neutralization of SARS-CoV-2 variants and robustness against viral escape Fangqiang Zhu, Saravanan Rajan, Conor F. Hayes, Ka Yin Kwong, Andre R. Goncalves, Adam T. Zemla, et al. (+38)
3 [GO] 2025―Mrz―14 SARS-related coronavirus S-protein structures reveal synergistic RBM interactions underpinning high-affinity human ACE2 binding Jingjing Wang, Yong Ma, Zimu Li, Hang Yuan, Banghui Liu, Zexuan Li, et al. (+12)
4 [GO] 2025―Feb―26 Increased SARS-CoV-2 IgG4 has variable consequences dependent upon Fc function, Fc receptor polymorphism, and viral variant L. Carissa Aurelia, Ruth A. Purcell, Robert M. Theisen, Andrew Kelly, Robyn Esterbauer, Pradhipa Ramanathan, et al. (+16)
5 [GO] 2025―Feb―12 Humoral responses to SARS-CoV-2 vaccine in vasculitis-related immune suppression Kimia Kamelian, Benjamin Sievers, Michael Chen-Xu, Sam Turner, Mark Tsz Kin Cheng, Mazharul Altaf, et al. (+13)
6 [GO] 2025―Feb―07 A SARS-CoV-2 vaccine on an NIR-II/SWIR emitting nanoparticle platform Yingying Jiang, Mrinmoy Sanyal, Noor A. Hussein, Ani Baghdasaryan, Mengzhen Zhang, Feifei Wang, et al. (+7)
7 [GO] 2025―Jan―29 Replication-incompetent VSV-based vaccine elicits protective responses against SARS-CoV-2 and influenza virus Richard A. Adeleke, Julie Sahler, Annette Choi, Kyle Roth, Viraj Upadhye, Shahrzad Ezzatpour, et al. (+8)
8 [GO] 2025―Jan―15 Barcoded SARS-CoV-2 viruses define the impact of duration and route of exposure on the transmission bottleneck in a hamster model Reed Trende, Tamarand L. Darling, Tianyu Gan, David Wang, Adrianus C. M. Boon
9 [GO] 2025―Jan―10 Ultrasensitive detection of intact SARS-CoV-2 particles in complex biofluids using microfluidic affinity capture Daniel C. Rabe, Adarsh Choudhury, Dasol Lee, Evelyn G. Luciani, Uyen K. Ho, Alex E. Clark, et al. (+20)
10 [GO] 2024―Dez―13 Effect of pandemic influenza A virus PB1 genes of avian origin on viral RNA polymerase activity and pathogenicity Stephanie L. Williams, Li Qi, Zong-Mei Sheng, Yongli Xiao, Ashley Freeman, Lex Matthews, et al. (+3)
11 [GO] 2024―Okt―11 Erratum for the Research Article: “Epidemic outcomes following government responses to COVID-19: Insights from nearly 100,000 models”
12 [GO] 2024―Aug―30 Discovery of SARS-CoV-2 papain-like protease (PL pro ) inhibitors with efficacy in a murine infection model Michelle R. Garnsey, Matthew C. Robinson, Luong T. Nguyen, Rhonda Cardin, Joseph Tillotson, Ellene Mashalidis, et al. (+34)
13 [GO] 2024―Aug―23 CD4 + and CD8 + T cells are required to prevent SARS-CoV-2 persistence in the nasal compartment Meenakshi Kar, Katherine E. E. Johnson, Abigail Vanderheiden, Elizabeth J. Elrod, Katharine Floyd, Elizabeth Geerling, et al. (+13)
14 [GO] 2024―Aug―07 Epitranscriptomic m 5 C methylation of SARS-CoV-2 RNA regulates viral replication and the virulence of progeny viruses in the new infection Hongyun Wang, Jiangpeng Feng, Zhiying Fu, Tianmo Xu, Jiejie Liu, Shimin Yang, et al. (+10)
15 [GO] 2024―Aug―02 A specific phosphorylation-dependent conformational switch in SARS-CoV-2 nucleocapsid protein inhibits RNA binding Maiia Botova, Aldo R. Camacho-Zarco, Jacqueline Tognetti, Luiza Mamigonian Bessa, Serafima Guseva, Emmi Mikkola, et al. (+4)
16 [GO] 2024―Jul―31 Immediate myeloid depot for SARS-CoV-2 in the human lung Mélia Magnen, Ran You, Arjun A. Rao, Ryan T. Davis, Lauren Rodriguez, Olivier Bernard, et al. (+20)
17 [GO] 2024―Jul―31 Mucosal immunization with ChAd-SARS-CoV-2-S prevents sequential transmission of SARS-CoV-2 to unvaccinated hamsters Tamarand L. Darling, Houda H. Harastani, Astha Joshi, Traci L. Bricker, Nadia Soudani, Kuljeet Seehra, et al. (+3)
18 [GO] 2024―Jul―24 In vitro selection and analysis of SARS-CoV-2 nirmatrelvir resistance mutations contributing to clinical virus resistance surveillance Yuao Zhu, Irina Yurgelonis, Stephen Noell, Qingyi Yang, Shunjie Guan, Zhenghui Li, et al. (+19)
19 [GO] 2024―Jul―19 Large and unequal life expectancy declines during the COVID-19 pandemic in India in 2020 Aashish Gupta, Payal Hathi, Murad Banaji, Prankur Gupta, Ridhi Kashyap, Vipul Paikra, et al. (+4)
20 [GO] 2024―Jul―17 Single-molecule imaging reveals allosteric stimulation of SARS-CoV-2 spike receptor binding domain by host sialic acid Marco A. Díaz-Salinas, Aastha Jain, Natasha D. Durham, James B. Munro
21 [GO] 2024―Jun―12 COVID-19 point-of-care tests can identify low-antibody individuals: In-depth immunoanalysis of boosting benefits in a healthy cohort Michael Mallory, Jennifer E. Munt, Tara M. Narowski, Izabella Castillo, Edwing Cuadra, Nora Pisanic, et al. (+14)
22 [GO] 2024―Jun―05 Epidemic outcomes following government responses to COVID-19: Insights from nearly 100,000 models Eran Bendavid, Chirag J. Patel
23 [GO] 2024―Jun―05 Choroid plexus defects in Down syndrome brain organoids enhance neurotropism of SARS-CoV-2 Mohammed R. Shaker, Andrii Slonchak, Bahaa Al-mhanawi, Sean D. Morrison, Julian D. J. Sng, Justin Cooper-White, et al. (+2)
24 [GO] 2024―Mai―31 Exploring the Big Data Paradox for various estimands using vaccination data from the global COVID-19 Trends and Impact Survey (CTIS) Youqi Yang, Walter Dempsey, Peisong Han, Yashwant Deshmukh, Sylvia Richardson, Brian Tom, Bhramar Mukherjee
25 [GO] 2024―Mai―24 Longitudinal plasma proteomic analysis of 1117 hospitalized patients with COVID-19 identifies features associated with severity and outcomes Arthur Viode, Kinga K. Smolen, Patrick van Zalm, David Stevenson, Meenakshi Jha, Kenneth Parker, et al. (+3)
26 [GO] 2024―Apr―10 Developing nucleoside tailoring strategies against SARS-CoV-2 via ribonuclease targeting chimera Yuanqin Min, Wei Xiong, Wei Shen, Xingyu Liu, Qianqian Qi, Yuanyuan Zhang, et al. (+8)
27 [GO] 2024―Apr―03 ER-export and ARFRP1/AP-1-dependent delivery of SARS-CoV-2 Envelope to lysosomes controls late stages of viral replication Guy J. Pearson, Harriet V. Mears, Malgorzata Broncel, Ambrosius P. Snijders, David L. V. Bauer, Jeremy G. Carlton
28 [GO] 2024―Mrz―06 Zeolitic imidazolate frameworks activate endosomal Toll-like receptors and potentiate immunogenicity of SARS-CoV-2 spike protein trimer Shahad K. Alsaiari, Seba Nadeef, John L. Daristotle, William Rothwell, Bujie Du, Johnny Garcia, et al. (+12)
29 [GO] 2024―Mrz―01 How the COVID-19 pandemic signaled the demise of Antarctic exceptionalism Daniela Liggett, Bob Frame, Peter Convey, Kevin A. Hughes
30 [GO] 2024―Feb―28 Rise in broadly cross-reactive adaptive immunity against human β-coronaviruses in MERS-recovered patients during the COVID-19 pandemic So-Hee Kim, Yuri Kim, Sangeun Jeon, Uni Park, Ju-Il Kang, Kyeongseok Jeon, et al. (+15)
31 [GO] 2024―Feb―28 Synthesis, insertion, and characterization of SARS-CoV-2 membrane protein within lipid bilayers Yuanzhong Zhang, Sara Anbir, Joseph McTiernan, Siyu Li, Michael Worcester, Pratyasha Mishra, et al. (+5)
32 [GO] 2024―Feb―21 Spontaneous, persistent, T cell-dependent IFN-γ release in patients who progress to Long Covid Benjamin A. Krishna, Eleanor Y. Lim, Marina Metaxaki, Sarah Jackson, Lenette Mactavous, Paul A. Lyons, et al. (+8)
33 [GO] 2024―Jan―26 Climate change, society, and pandemic disease in Roman Italy between 200 BCE and 600 CE Karin A. F. Zonneveld, Kyle Harper, Andreas Klügel, Liang Chen, Gert De Lange, Gerard J. M. Versteegh
34 [GO] 2024―Jan―03 Adaptive immune cells are necessary for SARS-CoV-2-induced pathology Brian Imbiakha, Julie M. Sahler, David W. Buchholz, Shahrzad Ezzatpour, Mason Jager, Annette Choi, et al. (+9)
35 [GO] 2023―Dez―20 Transformation of social relationships in COVID-19 America: Remote communication may amplify political echo chambers Byungkyu Lee, Kangsan Lee, Benjamin Hartmann
36 [GO] 2023―Dez―20 Design and analysis heterogeneity in observational studies of COVID-19 booster effectiveness: A review and case study Sabir Meah, Xu Shi, Lars G. Fritsche, Maxwell Salvatore, Abram Wagner, Emily T. Martin, Bhramar Mukherjee
37 [GO] 2023―Dez―01 Excess mortality in U.S. prisons during the COVID-19 pandemic Naomi F. Sugie, Kristin Turney, Keramet Reiter, Rebecca Tublitz, Daniela Kaiser, Rebecca Goodsell, et al. (+3)
38 [GO] 2023―Okt―13 Atomic structure of the open SARS-CoV-2 E viroporin João Medeiros-Silva, Aurelio J. Dregni, Noah H. Somberg, Pu Duan, Mei Hong
39 [GO] 2023―Okt―12 First-in-human immunoPET imaging of COVID-19 convalescent patients using dynamic total-body PET and a CD8-targeted minibody Negar Omidvari, Terry Jones, Pat M. Price, April L. Ferre, Jacqueline Lu, Yasser G. Abdelhafez, et al. (+7)
40 [GO] 2023―Okt―12 Characterization of the antispike IgG immune response to COVID-19 vaccines in people with a wide variety of immunodeficiencies Mackenzie Zendt, Fausto A. Bustos Carrillo, Sophie Kelly, Taylor Saturday, Maureen DeGrange, Anita Ginigeme, et al. (+41)
41 [GO] 2023―Sep―22 Unexpected vaginal bleeding and COVID-19 vaccination in nonmenstruating women Kristine Blix, Ida Laake, Lene Juvet, Anna Hayman Robertson, Ida Henriette Caspersen, Siri Mjaaland, et al. (+4)
42 [GO] 2023―Sep―22 Intranasal mRNA-LNP vaccination protects hamsters from SARS-CoV-2 infection Gabriela Baldeon Vaca, Michelle Meyer, Ana Cadete, Chiaowen Joyce Hsiao, Anne Golding, Albert Jeon, et al. (+14)
43 [GO] 2023―Sep―22 Age-dependent acquisition of pathogenicity by SARS-CoV-2 Omicron BA.5 Brian Imbiakha, Shahrzad Ezzatpour, David W. Buchholz, Julie Sahler, Chengjin Ye, Ximena A. Olarte-Castillo, et al. (+12)
44 [GO] 2023―Sep―15 The efficacy of Facebook’s vaccine misinformation policies and architecture during the COVID-19 pandemic David A. Broniatowski, Joseph R. Simons, Jiayan Gu, Amelia M. Jamison, Lorien C. Abroms
45 [GO] 2023―Aug―02 Quantifying the impact of SARS-CoV-2 temporal vaccination trends and disparities on disease control Sophie L. Larsen, Ikgyu Shin, Jefrin Joseph, Haylee West, Rafael Anorga, Gonzalo E. Mena, et al. (+2)
46 [GO] 2023―Jul―28 The worldwide COVID-19 lockdown impacts on global secondary inorganic aerosols and radiative budget Takashi Sekiya, Kazuyuki Miyazaki, Henk Eskes, Kevin Bowman, Kengo Sudo, Yugo Kanaya, Masayuki Takigawa
47 [GO] 2023―Jun―23 Monthly excess mortality across counties in the United States during the COVID-19 pandemic, March 2020 to February 2022 Eugenio Paglino, Dielle J. Lundberg, Zhenwei Zhou, Joe A. Wasserman, Rafeya Raquib, Anneliese N. Luck, et al. (+5)
48 [GO] 2023―Jun―23 A SARS-CoV-2 and influenza double hit vaccine based on RBD-conjugated inactivated influenza A virus Zhenzhen Wang, Zhenhua Li, Weiwei Shi, Dashuai Zhu, Shiqi Hu, Phuong-Uyen C. Dinh, Ke Cheng
49 [GO] 2023―Jun―21 Pharmacological modulators of epithelial immunity uncovered by synthetic genetic tracing of SARS-CoV-2 infection responses Ben Jiang, Matthias Jürgen Schmitt, Ulfert Rand, Carlos Company, Yuliia Dramaretska, Melanie Grossmann, et al. (+3)
50 [GO] 2023―Jun―14 Inhalation delivery of dexamethasone with iSEND nanoparticles attenuates the COVID-19 cytokine storm in mice and nonhuman primates Qian-Fang Meng, Wanbo Tai, Mingyao Tian, Xinyu Zhuang, Yuanwei Pan, Jialin Lai, et al. (+12)
51 [GO] 2023―Jun―14 CD62L expression marks SARS-CoV-2 memory B cell subset with preference for neutralizing epitopes Taishi Onodera, Nicolas Sax, Takashi Sato, Yu Adachi, Ryutaro Kotaki, Takeshi Inoue, et al. (+19)
52 [GO] 2023―Jun―09 Alternative epidemic indicators for COVID-19 in three settings with incomplete death registration systems Ruth McCabe, Charles Whittaker, Richard J. Sheppard, Nada Abdelmagid, Aljaile Ahmed, Israa Zain Alabdeen, et al. (+24)
53 [GO] 2023―Jun―07 SARS-CoV-2 infection and viral fusogens cause neuronal and glial fusion that compromises neuronal activity Ramón Martínez-Mármol, Rosina Giordano-Santini, Eva Kaulich, Ann-Na Cho, Magdalena Przybyla, Md Asrafuzzaman Riyadh, et al. (+9)
54 [GO] 2023―Jun―07 Structural and computational design of a SARS-CoV-2 spike antigen with improved expression and immunogenicity James A. Williams, Marco Biancucci, Laura Lessen, Sai Tian, Ankita Balsaraf, Lynn Chen, et al. (+10)
55 [GO] 2023―Apr―10 Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors Seyed Arad Moghadasi, Emmanuel Heilmann, Ahmed Magdy Khalil, Christina Nnabuife, Fiona L. Kearns, Chengjin Ye, et al. (+9)
56 [GO] 2023―Apr―07 The critical role of engineering in the rapid development of COVID-19 diagnostics: Lessons from the RADx Tech Test Verification Core Robert G. Mannino, Eric J. Nehl, Sarah Farmer, Amanda Foster Peagler, Maren C. Parsell, Viviana Claveria, et al. (+5)
57 [GO] 2023―Apr―05 A conserved oligomerization domain in the disordered linker of coronavirus nucleocapsid proteins Huaying Zhao, Di Wu, Sergio A. Hassan, Ai Nguyen, Jiji Chen, Grzegorz Piszczek, Peter Schuck
58 [GO] 2023―Mrz―31 Human disturbance increases coronavirus prevalence in bats Vera M. Warmuth, Dirk Metzler, Veronica Zamora-Gutierrez
59 [GO] 2023―Jan―20 Altered host protease determinants for SARS-CoV-2 Omicron Jasper Fuk-Woo Chan, Xiner Huang, Bingjie Hu, Yue Chai, Hongyu Shi, Tianrenzheng Zhu, et al. (+18)
60 [GO] 2023―Jan―18 Using digital traces to build prospective and real-time county-level early warning systems to anticipate COVID-19 outbreaks in the United States Lucas M. Stolerman, Leonardo Clemente, Canelle Poirier, Kris V. Parag, Atreyee Majumder, Serge Masyn, et al. (+2)
61 [GO] 2023―Jan―04 Spleen tyrosine kinase inhibition restores myeloid homeostasis in COVID-19 Gustaf Wigerblad, Seth A. Warner, Marcos J. Ramos-Benitez, Lela Kardava, Xin Tian, Rui Miao, et al. (+16)
62 [GO] 2022―Dez―23 The D614G mutation redirects SARS-CoV-2 spike to lysosomes and suppresses deleterious traits of the furin cleavage site insertion mutation Chenxu Guo, Shang-Jui Tsai, Yiwei Ai, Maggie Li, Eduardo Anaya, Andrew Pekosz, et al. (+2)
63 [GO] 2022―Dez―23 Manganese-coordinated mRNA vaccines with enhanced mRNA expression and immunogenicity induce robust immune responses against SARS-CoV-2 variants Na Fan, Kepan Chen, Rong Zhu, Zhongwei Zhang, Hai Huang, Shugang Qin, et al. (+12)
64 [GO] 2022―Dez―23 Erratum for the Research Article: “Differential proinflammatory activities of Spike proteins of SARS-CoV-2 variants of concern”
65 [GO] 2022―Dez―21 Nirmatrelvir-resistant SARS-CoV-2 variants with high fitness in an infectious cell culture system Yuyong Zhou, Karen Anbro Gammeltoft, Line Abildgaard Ryberg, Long V. Pham, Helena Damtoft Tjørnelund, Alekxander Binderup, et al. (+8)
66 [GO] 2022―Dez―09 Biochemical and structural insights into SARS-CoV-2 polyprotein processing by Mpro Ruchi Yadav, Valentine V. Courouble, Sanjay K. Dey, Jerry Joe E. K. Harrison, Jennifer Timm, Jesse B. Hopkins, et al. (+5)
67 [GO] 2022―Dez―09 Single-virus tracking reveals variant SARS-CoV-2 spike proteins induce ACE2-independent membrane interactions Shaun M. Christie, Takuya Tada, Yandong Yin, Amit Bhardwaj, Nathaniel R. Landau, Eli Rothenberg
68 [GO] 2022―Dez―07 Optimized ACE2 decoys neutralize antibody-resistant SARS-CoV-2 variants through functional receptor mimicry and treat infection in vivo James A. Torchia, Alexander H. Tavares, Laura S. Carstensen, Da-Yuan Chen, Jessie Huang, Tianshu Xiao, et al. (+10)
69 [GO] 2022―Nov―30 The SARS-CoV-2 spike protein binds and modulates estrogen receptors Oscar Solis, Andrea R. Beccari, Daniela Iaconis, Carmine Talarico, Camilo A. Ruiz-Bedoya, Jerome C. Nwachukwu, et al. (+25)
70 [GO] 2022―Nov―23 The free fatty acid-binding pocket is a conserved hallmark in pathogenic β-coronavirus spike proteins from SARS-CoV to Omicron Christine Toelzer, Kapil Gupta, Sathish K. N. Yadav, Lorna Hodgson, Maia Kavanagh Williamson, Dora Buzas, et al. (+14)
71 [GO] 2022―Nov―23 Protection against SARS-CoV-2 Omicron BA.1 variant challenge in macaques by prime-boost vaccination with Ad26.COV2.S and SpFN Jingyou Yu, Paul V. Thomas, Katherine McMahan, Catherine Jacob-Dolan, Jinyan Liu, Xuan He, et al. (+36)
72 [GO] 2022―Nov―23 Probing the biophysical constraints of SARS-CoV-2 spike N-terminal domain using deep mutational scanning Wenhao O. Ouyang, Timothy J.C. Tan, Ruipeng Lei, Ge Song, Collin Kieffer, Raiees Andrabi, et al. (+2)
73 [GO] 2022―Nov―18 SARS-CoV-2 Omicron BA.1 and BA.2 are attenuated in rhesus macaques as compared to Delta Neeltje van Doremalen, Manmeet Singh, Taylor A. Saturday, Claude Kwe Yinda, Lizzette Perez-Perez, W. Forrest Bohler, et al. (+15)
74 [GO] 2022―Nov―11 High-temporal resolution profiling reveals distinct immune trajectories following the first and second doses of COVID-19 mRNA vaccines Darawan Rinchai, Sara Deola, Gabriele Zoppoli, Basirudeen Syed Ahamed Kabeer, Sara Taleb, Igor Pavlovski, et al. (+36)
75 [GO] 2022―Okt―26 De novo selected hACE2 mimics that integrate hotspot peptides with aptameric scaffolds for binding tolerance of SARS-CoV-2 variants Minjong Lee, Byunghwa Kang, Juhwa Lee, Jisun Lee, Sang Taek Jung, Chang Yun Son, Seung Soo Oh
76 [GO] 2022―Okt―17 Policies to influence perceptions about COVID-19 risk: The case of maps Claudia Engel, Jonathan Rodden, Marco Tabellini
77 [GO] 2022―Okt―07 Severe COVID-19 induces autoantibodies against angiotensin II that correlate with blood pressure dysregulation and disease severity Priscilla S. Briquez, Sherin J. Rouhani, Jovian Yu, Athalia R. Pyzer, Jonathan Trujillo, Haley L. Dugan, et al. (+7)
78 [GO] 2022―Okt―05 Structural insights for neutralization of Omicron variants BA.1, BA.2, BA.4, and BA.5 by a broadly neutralizing SARS-CoV-2 antibody Sanjeev Kumar, Anamika Patel, Lilin Lai, Chennareddy Chakravarthy, Rajesh Valanparambil, Elluri Seetharami Reddy, et al. (+28)
79 [GO] 2022―Sep―30 COVID-19 Exposure Assessment Tool (CEAT): Exposure quantification based on ventilation, infection prevalence, group characteristics, and behavior Brian J. Schimmoller, Nídia S. Trovão, Molly Isbell, Chirag Goel, Benjamin F. Heck, Tenley C. Archer, et al. (+5)
80 [GO] 2022―Sep―28 Losing the battle over best-science guidance early in a crisis: COVID-19 and beyond Lucia Illari, Nicholas J. Restrepo, Neil F. Johnson
81 [GO] 2022―Sep―28 Microfluidic affinity selection of active SARS-CoV-2 virus particles Sachindra S. T. Gamage, Thilanga N. Pahattuge, Harshani Wijerathne, Katie Childers, Swarnagowri Vaidyanathan, Uditha S. Athapattu, et al. (+16)
82 [GO] 2022―Sep―23 Role for N -glycans and calnexin-calreticulin chaperones in SARS-CoV-2 Spike maturation and viral infectivity Qi Yang, Anju Kelkar, Anirudh Sriram, Ryoma Hombu, Thomas A. Hughes, Sriram Neelamegham
83 [GO] 2022―Sep―21 SARS-CoV-2 disrupts respiratory vascular barriers by suppressing Claudin-5 expression Rina Hashimoto, Junya Takahashi, Keisuke Shirakura, Risa Funatsu, Kaori Kosugi, Sayaka Deguchi, et al. (+26)
84 [GO] 2022―Sep―16 Differential proinflammatory activities of Spike proteins of SARS-CoV-2 variants of concern Sylwia D. Tyrkalska, Alicia Martínez-López, Ana B. Arroyo, Francisco J. Martínez-Morcillo, Sergio Candel, Diana García-Moreno, et al. (+3)
85 [GO] 2022―Sep―14 Identification of immunomodulatory drugs that inhibit multiple inflammasomes and impair SARS-CoV-2 infection Letícia de Almeida, Alexandre L. N. da Silva, Tamara S. Rodrigues, Samuel Oliveira, Adriene Y. Ishimoto, Amanda A. Seribelli, et al. (+19)
86 [GO] 2022―Sep―14 Design of the SARS-CoV-2 RBD vaccine antigen improves neutralizing antibody response Thayne H. Dickey, Wai Kwan Tang, Brandi Butler, Tarik Ouahes, Sachy Orr-Gonzalez, Nichole D. Salinas, et al. (+2)
87 [GO] 2022―Aug―24 (E1)levating COVID-19 vaccine efficiency with adenoviral E1 proteins Douglas R. Green, Paul G. Thomas
88 [GO] 2022―Aug―24 Comparison of replicating and nonreplicating vaccines against SARS-CoV-2 Haley E. Mudrick, Shane Massey, Erin B. McGlinch, Brian J. Parrett, Jack R. Hemsath, Mary E. Barry, et al. (+14)
89 [GO] 2022―Aug―24 Femtomolar detection of SARS-CoV-2 via peptide beacons integrated on a miniaturized TIRF microscope Soumya P. Tripathy, Manvitha Ponnapati, Suhaas Bhat, Joseph Jacobson, Pranam Chatterjee
90 [GO] 2022―Aug―19 Intermediates in SARS-CoV-2 spike-mediated cell entry Tara C. Marcink, Thomas Kicmal, Emily Armbruster, Zhening Zhang, Gillian Zipursky, Kate L. Golub, et al. (+8)
91 [GO] 2022―Aug―17 Complement C3 inhibition in severe COVID-19 using compstatin AMY-101 Panagiotis Skendros, Georgios Germanidis, Dimitrios C. Mastellos, Christina Antoniadou, Efstratios Gavriilidis, Georgios Kalopitas, et al. (+29)
92 [GO] 2022―Aug―03 Cell surface SARS-CoV-2 nucleocapsid protein modulates innate and adaptive immunity Alberto Domingo López-Muñoz, Ivan Kosik, Jaroslav Holly, Jonathan W. Yewdell
93 [GO] 2022―Jul―20 Tunneling nanotubes provide a route for SARS-CoV-2 spreading Anna Pepe, Stefano Pietropaoli, Matthijn Vos, Giovanna Barba-Spaeth, Chiara Zurzolo
94 [GO] 2022―Jul―15 Investigating trends in those who experience menstrual bleeding changes after SARS-CoV-2 vaccination Katharine M. N. Lee, Eleanor J. Junkins, Chongliang Luo, Urooba A. Fatima, Maria L. Cox, Kathryn B. H. Clancy
95 [GO] 2022―Jul―13 Engineered ACE2-Fc counters murine lethal SARS-CoV-2 infection through direct neutralization and Fc-effector activities Yaozong Chen, Lulu Sun, Irfan Ullah, Guillaume Beaudoin-Bussières, Sai Priya Anand, Andrew P. Hederman, et al. (+17)
96 [GO] 2022―Jun―17 Lessons from SARS-CoV-2 in India: A data-driven framework for pandemic resilience Maxwell Salvatore, Soumik Purkayastha, Lakshmi Ganapathi, Rupam Bhattacharyya, Ritoban Kundu, Lauren Zimmermann, et al. (+6)
97 [GO] 2022―Jun―07 Neighborhood socioeconomic inequality based on everyday mobility predicts COVID-19 infection in San Francisco, Seattle, and Wisconsin Brian L. Levy, Karl Vachuska, S. V. Subramanian, Robert J. Sampson
98 [GO] 2022―Jun―03 Microfluidic particle dam for direct visualization of SARS-CoV-2 antibody levels in COVID-19 vaccinees Minghui Wu, Siying Wu, Gaobo Wang, Wengang Liu, Lok Ting Chu, Tianyi Jiang, et al. (+4)
99 [GO] 2022―Jun―01 A systems biology approach identifies candidate drugs to reduce mortality in severely ill patients with COVID-19 Vinicius M. Fava, Mathieu Bourgey, Pubudu M. Nawarathna, Marianna Orlova, Pauline Cassart, Donald C. Vinh, et al. (+4)
100 [GO] 2022―Mai―27 The mechanisms of catalysis and ligand binding for the SARS-CoV-2 NSP3 macrodomain from neutron and x-ray diffraction at room temperature Galen J. Correy, Daniel W. Kneller, Gwyndalyn Phillips, Swati Pant, Silvia Russi, Aina E. Cohen, et al. (+9)
101 [GO] 2022―Mai―25 Quantitative and ultrasensitive in situ immunoassay technology for SARS-CoV-2 detection in saliva Yuchao Chen, Fei Liu, Luke P. Lee
102 [GO] 2022―Mai―13 Detecting anti-SARS-CoV-2 antibodies in urine samples: A noninvasive and sensitive way to assay COVID-19 immune conversion Fernanda Ludolf, Fernanda F. Ramos, Flávia F. Bagno, João A. Oliveira-da-Silva, Thiago A. R. Reis, Myron Christodoulides, et al. (+5)
103 [GO] 2022―Apr―29 High-resolution profiling of MHC II peptide presentation capacity reveals SARS-CoV-2 CD4 T cell targets and mechanisms of immune escape Franz-Josef Obermair, Florian Renoux, Sebastian Heer, Chloe H. Lee, Nastassja Cereghetti, Marisa Loi, et al. (+9)
104 [GO] 2022―Apr―27 COVID-19 vaccine hesitancy in eight European countries: Prevalence, determinants, and heterogeneity Janina I. Steinert, Henrike Sternberg, Hannah Prince, Barbara Fasolo, Matteo M. Galizzi, Tim Büthe, Giuseppe A. Veltri
105 [GO] 2022―Apr―22 Novel quantification of regional fossil fuel CO 2 reductions during COVID-19 lockdowns using atmospheric oxygen measurements Penelope A. Pickers, Andrew C. Manning, Corinne Le Quéré, Grant L. Forster, Ingrid T. Luijkx, Christoph Gerbig, et al. (+2)
106 [GO] 2022―Apr―20 In-person schooling and associated COVID-19 risk in the United States over spring semester 2021 Kirsten E. Wiens, Claire P. Smith, Elena Badillo-Goicoechea, Kyra H. Grantz, M. Kate Grabowski, Andrew S. Azman, et al. (+2)
107 [GO] 2022―Apr―15 One-year surveillance of SARS-CoV-2 transmission of the ELISA cohort: A model for population-based monitoring of infection risk Christine Klein, Max Borsche, Alexander Balck, Bandik Föh, Johann Rahmöller, Elke Peters, et al. (+24)
108 [GO] 2022―Apr―13 Time experience during social distancing: A longitudinal study during the first months of COVID-19 pandemic in Brazil André Mascioli Cravo, Gustavo Brito de Azevedo, Cristiano Moraes Bilacchi Azarias, Louise Catheryne Barne, Fernanda Dantas Bueno, Raphael Y. de Camargo, et al. (+5)
109 [GO] 2022―Apr―08 COVID-19 in low-tolerance border quarantine systems: Impact of the Delta variant of SARS-CoV-2 Cameron Zachreson, Freya M. Shearer, David J. Price, Michael J. Lydeamore, Jodie McVernon, James McCaw, Nicholas Geard
110 [GO] 2022―Mrz―25 Multivariate mining of an alpaca immune repertoire identifies potent cross-neutralizing SARS-CoV-2 nanobodies Leo Hanke, Daniel J. Sheward, Alec Pankow, Laura Perez Vidakovics, Vivien Karl, Changil Kim, et al. (+7)
111 [GO] 2022―Mrz―16 SARS-CoV-2 receptor binding domain displayed on HBsAg virus-like particles elicits protective immunity in macaques Neil C. Dalvie, Lisa H. Tostanoski, Sergio A. Rodriguez-Aponte, Kawaljit Kaur, Sakshi Bajoria, Ozan S. Kumru, et al. (+34)
112 [GO] 2022―Mrz―02 Assets, stressors, and symptoms of persistent depression over the first year of the COVID-19 pandemic Catherine K. Ettman, Gregory H. Cohen, Salma M. Abdalla, Ludovic Trinquart, Brian C. Castrucci, Rachel H. Bork, et al. (+4)
113 [GO] 2022―Feb―25 Large-scale implementation of rapid antigen testing system for COVID-19 in workplaces Laura C. Rosella, Ajay Agrawal, Joshua Gans, Avi Goldfarb, Sonia Sennik, Janice Stein
114 [GO] 2022―Feb―25 The transmission game: Testing behavioral interventions in a pandemic-like simulation Jan K. Woike, Sebastian Hafenbrädl, Patricia Kanngiesser, Ralph Hertwig
115 [GO] 2022―Feb―23 Cannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responses Long Chi Nguyen, Dongbo Yang, Vlad Nicolaescu, Thomas J. Best, Haley Gula, Divyasha Saxena, et al. (+26)
116 [GO] 2022―Feb―04 The costs and benefits of primary prevention of zoonotic pandemics Aaron S. Bernstein, Amy W. Ando, Ted Loch-Temzelides, Mariana M. Vale, Binbin V. Li, Hongying Li, et al. (+14)
117 [GO] 2022―Jan―28 Epidemiological characteristics of the B.1.526 SARS-CoV-2 variant Wan Yang, Sharon K. Greene, Eric R. Peterson, Wenhui Li, Robert Mathes, Laura Graf, et al. (+4)
118 [GO] 2022―Jan―26 SARS-CoV-2 epidemic after social and economic reopening in three U.S. states reveals shifts in age structure and clinical characteristics Nathan B. Wikle, Thu Nguyen-Anh Tran, Bethany Gentilesco, Scott M. Leighow, Emmy Albert, Emily R. Strong, et al. (+10)
119 [GO] 2022―Jan―19 Lack of practical identifiability may hamper reliable predictions in COVID-19 epidemic models Luca Gallo, Mattia Frasca, Vito Latora, Giovanni Russo
120 [GO] 2022―Jan―19 Preclinical evaluation of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B Jun Liu, Patrick Budylowski, Reuben Samson, Bryan D. Griffin, Giorgi Babuadze, Bhavisha Rathod, et al. (+21)
121 [GO] 2022―Jan―19 The intrinsically disordered SARS-CoV-2 nucleoprotein in dynamic complex with its viral partner nsp3a Luiza Mamigonian Bessa, Serafima Guseva, Aldo R. Camacho-Zarco, Nicola Salvi, Damien Maurin, Laura Mariño Perez, et al. (+6)
122 [GO] 2022―Jan―07 Impact of close interpersonal contact on COVID-19 incidence: Evidence from 1 year of mobile device data Forrest W. Crawford, Sydney A. Jones, Matthew Cartter, Samantha G. Dean, Joshua L. Warren, Zehang Richard Li, et al. (+5)
123 [GO] 2022―Jan―07 Toward wide-spectrum antivirals against coronaviruses: Molecular characterization of SARS-CoV-2 NSP13 helicase inhibitors Gustavo R. Perez-Lemus, Cintia A. Menéndez, Walter Alvarado, Fabian Byléhn, Juan J. de Pablo
124 [GO] 2022―Jan―07 A lethal mouse model for evaluating vaccine-associated enhanced respiratory disease during SARS-CoV-2 infection Naoko Iwata-Yoshikawa, Nozomi Shiwa, Tsuyoshi Sekizuka, Kaori Sano, Akira Ainai, Takuya Hemmi, et al. (+5)
125 [GO] 2022―Jan―07 SARS-CoV-2 nucleocapsid protein adheres to replication organelles before viral assembly at the Golgi/ERGIC and lysosome-mediated egress Katharina M. Scherer, Luca Mascheroni, George W. Carnell, Lucia C. S. Wunderlich, Stanislaw Makarchuk, Marius Brockhoff, et al. (+10)
126 [GO] 2021―Dez―15 Harmony COVID-19: A ready-to-use kit, low-cost detector, and smartphone app for point-of-care SARS-CoV-2 RNA detection Nuttada Panpradist, Enos C. Kline, Robert G. Atkinson, Michael Roller, Qin Wang, Ian T. Hull, et al. (+11)
127 [GO] 2021―Dez―08 Phosphate-mediated coanchoring of RBD immunogens and molecular adjuvants to alum potentiates humoral immunity against SARS-CoV-2 Kristen A. Rodrigues, Sergio A. Rodriguez-Aponte, Neil C. Dalvie, Jeong Hyun Lee, Wuhbet Abraham, Diane G. Carnathan, et al. (+16)
128 [GO] 2021―Dez―08 TREM-2 is a sensor and activator of T cell response in SARS-CoV-2 infection Yongjian Wu, Manni Wang, Huan Yin, Siqi Ming, Xingyu Li, Guanmin Jiang, et al. (+8)
129 [GO] 2021―Dez―03 Rapid test to assess the escape of SARS-CoV-2 variants of concern Jacob T. Heggestad, Rhett J. Britton, David S. Kinnamon, Simone A. Wall, Daniel Y. Joh, Angus M. Hucknall, et al. (+11)
130 [GO] 2021―Dez―01 Lyophilized, thermostable Spike or RBD immunogenic liposomes induce protective immunity against SARS-CoV-2 in mice Moustafa T. Mabrouk, Kevin Chiem, Edurne Rujas, Wei-Chiao Huang, Dushyant Jahagirdar, Breandan Quinn, et al. (+10)
131 [GO] 2021―Dez―01 Live attenuated virus vaccine protects against SARS-CoV-2 variants of concern B.1.1.7 (Alpha) and B.1.351 (Beta) Jakob Trimpert, Julia M. Adler, Kathrin Eschke, Azza Abdelgawad, Theresa C. Firsching, Nadine Ebert, et al. (+5)
132 [GO] 2021―Nov―26 Integrated immunovirological profiling validates plasma SARS-CoV-2 RNA as an early predictor of COVID-19 mortality Elsa Brunet-Ratnasingham, Sai Priya Anand, Pierre Gantner, Alina Dyachenko, Gaël Moquin-Beaudry, Nathalie Brassard, et al. (+37)
133 [GO] 2021―Nov―26 Amilorides inhibit SARS-CoV-2 replication in vitro by targeting RNA structures Martina Zafferani, Christina Haddad, Le Luo, Jesse Davila-Calderon, Liang-Yuan Chiu, Christian Shema Mugisha, et al. (+10)
134 [GO] 2021―Nov―10 A regulatory T cell signature distinguishes the immune landscape of COVID-19 patients from those with other respiratory infections Sarah C. Vick, Marie Frutoso, Florian Mair, Andrew J. Konecny, Evan Greene, Caitlin R. Wolf, et al. (+8)
135 [GO] 2021―Nov―03 Regional impacts of COVID-19 on carbon dioxide detected worldwide from space Brad Weir, David Crisp, Christopher W. O’Dell, Sourish Basu, Abhishek Chatterjee, Jana Kolassa, et al. (+8)
136 [GO] 2021―Okt―29 Complete protection by a single-dose skin patch-delivered SARS-CoV-2 spike vaccine Christopher L. D. McMillan, Jovin J. Y. Choo, Adi Idris, Aroon Supramaniam, Naphak Modhiran, Alberto A. Amarilla, et al. (+14)
137 [GO] 2021―Okt―23 Safe traveling in public transport amid COVID-19 Donggyun Ku, Chihyung Yeon, Seungjae Lee, Kyuhong Lee, Kiyeon Hwang, Yuen Chong Li, Sze Chun Wong
138 [GO] 2021―Okt―23 Subtle differences in the pathogenicity of SARS-CoV-2 variants of concern B.1.1.7 and B.1.351 in rhesus macaques Vincent J. Munster, Meaghan Flagg, Manmeet Singh, Claude Kwe Yinda, Brandi N. Williamson, Friederike Feldmann, et al. (+14)
139 [GO] 2021―Okt―21 Mechanism of a COVID-19 nanoparticle vaccine candidate that elicits a broadly neutralizing antibody response to SARS-CoV-2 variants Yi-Nan Zhang, Jennifer Paynter, Cindy Sou, Tatiana Fourfouris, Ying Wang, Ciril Abraham, et al. (+4)
140 [GO] 2021―Okt―13 Transient lipid-bound states of spike protein heptad repeats provide insights into SARS-CoV-2 membrane fusion Sai Chaitanya Chiliveri, John M. Louis, Rodolfo Ghirlando, Ad Bax
141 [GO] 2021―Okt―13 Systemic and mucosal immune profiling in asymptomatic and symptomatic SARS-CoV-2-infected individuals reveal unlinked immune signatures Supriya Ravichandran, Gabrielle Grubbs, Juanjie Tang, Youri Lee, Chang Huang, Hana Golding, Surender Khurana
142 [GO] 2021―Okt―13 Low case numbers enable long-term stable pandemic control without lockdowns Sebastian Contreras, Jonas Dehning, Sebastian B. Mohr, Simon Bauer, F. Paul Spitzner, Viola Priesemann
143 [GO] 2021―Sep―29 Geographically targeted COVID-19 vaccination is more equitable and averts more deaths than age-based thresholds alone Elizabeth Wrigley-Field, Mathew V. Kiang, Alicia R. Riley, Magali Barbieri, Yea-Hung Chen, Kate A. Duchowny, et al. (+5)
144 [GO] 2021―Sep―22 Reduced human activity during COVID-19 alters avian land use across North America Michael B. Schrimpf, Paulson G. Des Brisay, Alison Johnston, Adam C. Smith, Jessica Sánchez-Jasso, Barry G. Robinson, et al. (+6)
145 [GO] 2021―Sep―22 Social media conversations reveal large psychological shifts caused by COVID-19’s onset across U.S. cities Ashwini Ashokkumar, James W. Pennebaker
146 [GO] 2021―Sep―22 Direct detection of human adenovirus or SARS-CoV-2 with ability to inform infectivity using DNA aptamer-nanopore sensors Ana S. Peinetti, Ryan J. Lake, Wen Cong, Laura Cooper, Yuting Wu, Yuan Ma, et al. (+7)
147 [GO] 2021―Sep―15 Ultrafast, sensitive, and portable detection of COVID-19 IgG using flexible organic electrochemical transistors Hong Liu, Anneng Yang, Jiajun Song, Naixiang Wang, Puiyiu Lam, Yuenling Li, et al. (+2)
148 [GO] 2021―Sep―10 Immunological and pathological outcomes of SARS-CoV-2 challenge following formalin-inactivated vaccine in ferrets and rhesus macaques Kevin R. Bewley, Karen Gooch, Kelly M. Thomas, Stephanie Longet, Nathan Wiblin, Laura Hunter, et al. (+36)
149 [GO] 2021―Sep―08 Platelets amplify endotheliopathy in COVID-19 Tessa J. Barrett, MacIntosh Cornwell, Khrystyna Myndzar, Christina C. Rolling, Yuhe Xia, Kamelia Drenkova, et al. (+18)
150 [GO] 2021―Sep―08 A universal bacteriophage T4 nanoparticle platform to design multiplex SARS-CoV-2 vaccine candidates by CRISPR engineering Jingen Zhu, Neeti Ananthaswamy, Swati Jain, Himanshu Batra, Wei-Chun Tang, Douglass A. Lewry, et al. (+8)
151 [GO] 2021―Sep―03 Emerging SARS-CoV-2 variants of concern evade humoral immune responses from infection and vaccination Tom G. Caniels, Ilja Bontjer, Karlijn van der Straten, Meliawati Poniman, Judith A. Burger, Brent Appelman, et al. (+22)
152 [GO] 2021―Aug―25 Rapid greening response of China’s 2020 spring vegetation to COVID-19 restrictions: Implications for climate change Fenzhen Su, Dongjie Fu, Fengqin Yan, Han Xiao, Tingting Pan, Yang Xiao, et al. (+8)
153 [GO] 2021―Aug―18 Age-dependent regulation of SARS-CoV-2 cell entry genes and cell death programs correlates with COVID-19 severity Zintis Inde, Ben A. Croker, Clarence Yapp, Gaurav N. Joshi, Johan Spetz, Cameron Fraser, et al. (+25)
154 [GO] 2021―Aug―18 Immune checkpoint inhibitors increase T cell immunity during SARS-CoV-2 infection Nader Yatim, Jeremy Boussier, Pauline Tetu, Nikaïa Smith, Timothée Bruel, Bruno Charbit, et al. (+23)
155 [GO] 2021―Aug―13 Excess of COVID-19 cases and deaths due to fine particulate matter exposure during the 2020 wildfires in the United States Xiaodan Zhou, Kevin Josey, Leila Kamareddine, Miah C. Caine, Tianjia Liu, Loretta J. Mickley, et al. (+2)
156 [GO] 2021―Aug―11 Cell therapy strategies for COVID-19: Current approaches and potential applications Mark M. Zaki, Emal Lesha, Khaled Said, Kiavash Kiaee, Lindsey Robinson-McCarthy, Haydy George, et al. (+6)
157 [GO] 2021―Aug―11 A general model for the demographic signatures of the transition from pandemic emergence to endemicity Ruiyun Li, C. Jessica E. Metcalf, Nils Chr. Stenseth, Ottar N. Bjørnstad
158 [GO] 2021―Aug―06 Minimally instrumented SHERLOCK (miSHERLOCK) for CRISPR-based point-of-care diagnosis of SARS-CoV-2 and emerging variants Helena de Puig, Rose A. Lee, Devora Najjar, Xiao Tan, Luis R. Soekensen, Nicolaas M. Angenent-Mari, et al. (+11)
159 [GO] 2021―Jul―30 SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay Michael J. Peluso, Saki Takahashi, Jill Hakim, J. Daniel Kelly, Leonel Torres, Nikita S. Iyer, et al. (+40)
160 [GO] 2021―Jul―28 Interdependent program evaluation: Geographic and social spillovers in COVID-19 closures and reopenings in the United States Michael Zhao, David Holtz, Sinan Aral
161 [GO] 2021―Jul―14 Meaningful messaging: Sentiment in elite social media communication with the public on the COVID-19 pandemic Janet M. Box-Steffensmeier, Laura Moses
162 [GO] 2021―Jul―02 Protection of K18-hACE2 mice and ferrets against SARS-CoV-2 challenge by a single-dose mucosal immunization with a parainfluenza virus 5-based COVID-19 vaccine Dong An, Kun Li, Dawne K. Rowe, Maria Cristina Huertas Diaz, Emily F. Griffin, Ashley C. Beavis, et al. (+14)
163 [GO] 2021―Jun―30 Identification of SARS-CoV-2-induced pathways reveals drug repurposing strategies Namshik Han, Woochang Hwang, Konstantinos Tzelepis, Patrick Schmerer, Eliza Yankova, Méabh MacMahon, et al. (+10)
164 [GO] 2021―Jun―25 Multiplexed, quantitative serological profiling of COVID-19 from blood by a point-of-care test Jacob T. Heggestad, David S. Kinnamon, Lyra B. Olson, Jason Liu, Garrett Kelly, Simone A. Wall, et al. (+18)
165 [GO] 2021―Jun―23 Effects of COVID-19 lockdowns on fine particulate matter concentrations Melanie S. Hammer, Aaron van Donkelaar, Randall V. Martin, Erin E. McDuffie, Alexei Lyapustin, Andrew M. Sayer, et al. (+5)
166 [GO] 2021―Jun―16 Targeting highly pathogenic coronavirus-induced apoptosis reduces viral pathogenesis and disease severity Hin Chu, Huiping Shuai, Yuxin Hou, Xi Zhang, Lei Wen, Xiner Huang, et al. (+19)
167 [GO] 2021―Jun―09 Global tropospheric ozone responses to reduced NOx emissions linked to the COVID-19 worldwide lockdowns Kazuyuki Miyazaki, Kevin Bowman, Takashi Sekiya, Masayuki Takigawa, Jessica L. Neu, Kengo Sudo, et al. (+2)
168 [GO] 2021―Mai―28 Immunization with RBD-P2 and N protects against SARS-CoV-2 in nonhuman primates So-Hee Hong, Hanseul Oh, Yong Wook Park, Hye Won Kwak, Eun Young Oh, Hyo-Jung Park, et al. (+30)
169 [GO] 2021―Mai―26 Inhalable Nanobody (PiN-21) prevents and treats SARS-CoV-2 infections in Syrian hamsters at ultra-low doses Sham Nambulli, Yufei Xiang, Natasha L. Tilston-Lunel, Linda J. Rennick, Zhe Sang, William B. Klimstra, et al. (+4)
170 [GO] 2021―Mai―26 Lessons from a pandemic for systems-oriented sustainability research Noelle E. Selin
171 [GO] 2021―Mai―21 Air pollution impacts of COVID-19-related containment measures Guillaume P. Chossière, Haofeng Xu, Yash Dixit, Stewart Isaacs, Sebastian D. Eastham, Florian Allroggen, et al. (+2)
172 [GO] 2021―Mai―12 Differential cardiopulmonary monitoring system for artifact-canceled physiological tracking of athletes, workers, and COVID-19 patients Hyoyoung Jeong, Jong Yoon Lee, KunHyuck Lee, Youn J. Kang, Jin-Tae Kim, Raudel Avila, et al. (+25)
173 [GO] 2021―Mai―07 The impact of relaxing interventions on human contact patterns and SARS-CoV-2 transmission in China Juanjuan Zhang, Maria Litvinova, Yuxia Liang, Wen Zheng, Huilin Shi, Alessandro Vespignani, et al. (+3)
174 [GO] 2021―Mai―06 Structural insights into the cross-neutralization of SARS-CoV and SARS-CoV-2 by the human monoclonal antibody 47D11 Juliette Fedry, Daniel L. Hurdiss, Chunyan Wang, Wentao Li, Gonzalo Obal, Ieva Drulyte, et al. (+5)
175 [GO] 2021―Apr―23 SARS-CoV-2 can recruit a haem metabolite to evade antibody immunity Annachiara Rosa, Valerie E. Pye, Carl Graham, Luke Muir, Jeffrey Seow, Kevin W. Ng, et al. (+34)
176 [GO] 2021―Apr―16 The SARS-CoV-2 Spike variant D614G favors an open conformational state Rachael A. Mansbach, Srirupa Chakraborty, Kien Nguyen, David C. Montefiori, Bette Korber, S. Gnanakaran
177 [GO] 2021―Apr―14 Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking Marion Schuller, Galen J. Correy, Stefan Gahbauer, Daren Fearon, Taiasean Wu, Roberto Efraín Díaz, et al. (+47)
178 [GO] 2021―Mrz―19 Symptom clusters in COVID-19: A potential clinical prediction tool from the COVID Symptom Study app Carole H. Sudre, Karla A. Lee, Mary Ni Lochlainn, Thomas Varsavsky, Benjamin Murray, Mark S. Graham, et al. (+27)
179 [GO] 2021―Mrz―19 Single-component, self-assembling, protein nanoparticles presenting the receptor binding domain and stabilized spike as SARS-CoV-2 vaccine candidates Linling He, Xiaohe Lin, Ying Wang, Ciril Abraham, Cindy Sou, Timothy Ngo, et al. (+3)
180 [GO] 2021―Mrz―17 Catalytic amplification by transition-state molecular switches for direct and sensitive detection of SARS-CoV-2 Noah R. Sundah, Auginia Natalia, Yu Liu, Nicholas R. Y. Ho, Haitao Zhao, Yuan Chen, et al. (+8)
181 [GO] 2021―Mrz―05 An early warning approach to monitor COVID-19 activity with multiple digital traces in near real time Nicole E. Kogan, Leonardo Clemente, Parker Liautaud, Justin Kaashoek, Nicholas B. Link, Andre T. Nguyen, et al. (+11)
182 [GO] 2021―Mrz―05 Longitudinal antibody repertoire in “mild” versus “severe” COVID-19 patients reveals immune markers associated with disease severity and resolution Supriya Ravichandran, Youri Lee, Gabrielle Grubbs, Elizabeth M. Coyle, Laura Klenow, Osamu Akasaka, et al. (+17)
183 [GO] 2021―Feb―24 Supporting women in academia during and after a global pandemic Tiffany A. Reese, Tamia A. Harris-Tryon, Jennifer G. Gill, Laura A. Banaszynski
184 [GO] 2021―Feb―22 Immunogenicity of clinically relevant SARS-CoV-2 vaccines in non-human primates and humans P. J. Klasse, Douglas F. Nixon, John P. Moore
185 [GO] 2021―Feb―17 An engineered decoy receptor for SARS-CoV-2 broadly binds protein S sequence variants Kui K. Chan, Timothy J. C. Tan, Krishna K. Narayanan, Erik Procko
186 [GO] 2021―Feb―14 INSIGHT: A population-scale COVID-19 testing strategy combining point-of-care diagnosis with centralized high-throughput sequencing Qianxin Wu, Chenqu Suo, Tom Brown, Tengyao Wang, Sarah A. Teichmann, Andrew R. Bassett
187 [GO] 2021―Feb―14 Insights into neutralizing antibody responses in individuals exposed to SARS-CoV-2 in Chile Carolina Beltrán-Pavez, Sebastián Riquelme-Barrios, Aarón Oyarzún-Arrau, Aracelly Gaete-Argel, Roxana González-Stegmaier, Karina Cereceda-Solis, et al. (+14)
188 [GO] 2021―Feb―09 A lymph node-targeted Amphiphile vaccine induces potent cellular and humoral immunity to SARS-CoV-2 Martin P. Steinbuck, Lochana M. Seenappa, Aniela Jakubowski, Lisa K. McNeil, Christopher M. Haqq, Peter C. DeMuth
189 [GO] 2021―Feb―09 Nsp1 protein of SARS-CoV-2 disrupts the mRNA export machinery to inhibit host gene expression Ke Zhang, Lisa Miorin, Tadashi Makio, Ishmael Dehghan, Shengyan Gao, Yihu Xie, et al. (+13)
190 [GO] 2021―Feb―08 Falling living standards during the COVID-19 crisis: Quantitative evidence from nine developing countries Dennis Egger, Edward Miguel, Shana S. Warren, Ashish Shenoy, Elliott Collins, Dean Karlan, et al. (+20)
191 [GO] 2021―Feb―03 Leveraging systems biology for predicting modulators of inflammation in patients with COVID-19 Sascha Jung, Ilya Potapov, Samyukta Chillara, Antonio del Sol
192 [GO] 2021―Feb―03 A diagnostic host response biosignature for COVID-19 from RNA profiling of nasal swabs and blood Dianna L. Ng, Andrea C. Granados, Yale A. Santos, Venice Servellita, Gregory M. Goldgof, Cem Meydan, et al. (+26)
193 [GO] 2021―Feb―03 Vaccine optimization for COVID-19: Who to vaccinate first? Laura Matrajt, Julia Eaton, Tiffany Leung, Elizabeth R. Brown
194 [GO] 2021―Jan―13 Abrupt but smaller than expected changes in surface air quality attributable to COVID-19 lockdowns Zongbo Shi, Congbo Song, Bowen Liu, Gongda Lu, Jingsha Xu, Tuan Van Vu, et al. (+4)
195 [GO] 2021―Jan―08 A smartphone-read ultrasensitive and quantitative saliva test for COVID-19 Bo Ning, Tao Yu, Shengwei Zhang, Zhen Huang, Di Tian, Zhen Lin, et al. (+11)
196 [GO] 2021―Jan―06 Partisan pandemic: How partisanship and public health concerns affect individuals’ social mobility during COVID-19 J. Clinton, J. Cohen, J. Lapinski, M. Trussler
197 [GO] 2021―Jan―01 Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening Daniel B. Larremore, Bryan Wilder, Evan Lester, Soraya Shehata, James M. Burke, James A. Hay, et al. (+3)
198 [GO] 2020―Dez―09 Distinct inflammatory profiles distinguish COVID-19 from influenza with limited contributions from cytokine storm Philip A. Mudd, Jeremy Chase Crawford, Jackson S. Turner, Aisha Souquette, Daniel Reynolds, Diane Bender, et al. (+13)
199 [GO] 2020―Dez―05 Differential effects of intervention timing on COVID-19 spread in the United States Sen Pei, Sasikiran Kandula, Jeffrey Shaman
200 [GO] 2020―Dez―05 Conformational dynamics of SARS-CoV-2 trimeric spike glycoprotein in complex with receptor ACE2 revealed by cryo-EM Cong Xu, Yanxing Wang, Caixuan Liu, Chao Zhang, Wenyu Han, Xiaoyu Hong, et al. (+13)
201 [GO] 2020―Dez―03 Satellite-based estimates of decline and rebound in China’s CO2 emissions during COVID-19 pandemic Bo Zheng, Guannan Geng, Philippe Ciais, Steven J. Davis, Randall V. Martin, Jun Meng, et al. (+10)
202 [GO] 2020―Nov―21 Damaged lung gas-exchange function of discharged COVID-19 patients detected by hyperpolarized 129Xe MRI Haidong Li, Xiuchao Zhao, Yujin Wang, Xin Lou, Shizhen Chen, He Deng, et al. (+7)
203 [GO] 2020―Nov―19 Social connections with COVID-19-affected areas increase compliance with mobility restrictions Ben Charoenwong, Alan Kwan, Vesa Pursiainen
204 [GO] 2020―Nov―14 JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality Justin Stebbing, Ginés Sánchez Nievas, Marco Falcone, Sonia Youhanna, Peter Richardson, Silvia Ottaviani, et al. (+44)
205 [GO] 2020―Nov―07 Structure and inhibition of the SARS-CoV-2 main protease reveals strategy for developing dual inhibitors against Mpro and cathepsin L Michael Dominic Sacco, Chunlong Ma, Panagiotis Lagarias, Ang Gao, Julia Alma Townsend, Xiangzhi Meng, et al. (+11)
206 [GO] 2020―Nov―05 Air pollution and COVID-19 mortality in the United States: Strengths and limitations of an ecological regression analysis X. Wu, R. C. Nethery, M. B. Sabath, D. Braun, F. Dominici
207 [GO] 2020―Nov―05 How air pollution may influence the course of pandemics Jeremy Jackson, Kip Hodges
208 [GO] 2020―Okt―30 Fatalities from COVID-19 are reducing Americans’ support for Republicans at every level of federal office Christopher Warshaw, Lynn Vavreck, Ryan Baxter-King
209 [GO] 2020―Okt―23 Potency and timing of antiviral therapy as determinants of duration of SARS-CoV-2 shedding and intensity of inflammatory response Ashish Goyal, E. Fabian Cardozo-Ojeda, Joshua T. Schiffer
210 [GO] 2020―Okt―16 Activity profiling and crystal structures of inhibitor-bound SARS-CoV-2 papain-like protease: A framework for anti-COVID-19 drug design Wioletta Rut, Zongyang Lv, Mikolaj Zmudzinski, Stephanie Patchett, Digant Nayak, Scott J. Snipas, et al. (+5)
211 [GO] 2020―Okt―09 Cross-reactive neutralization of SARS-CoV-2 by serum antibodies from recovered SARS patients and immunized animals Yuanmei Zhu, Danwei Yu, Yang Han, Hongxia Yan, Huihui Chong, Lili Ren, et al. (+3)
212 [GO] 2020―Sep―25 Model uncertainty, political contestation, and public trust in science: Evidence from the COVID-19 pandemic S.E. Kreps, D. L. Kriner
213 [GO] 2020―Sep―23 The unfolding COVID-19 pandemic: A probability-based, nationally representative study of mental health in the U.S. E. Alison Holman, Rebecca R. Thompson, Dana Rose Garfin, Roxane Cohen Silver
214 [GO] 2020―Sep―18 Antibody-like proteins that capture and neutralize SARS-CoV-2 T. Kondo, Y. Iwatani, K. Matsuoka, T. Fujino, S. Umemoto, Y. Yokomaku, et al. (+5)
215 [GO] 2020―Sep―16 Reimagining scientific conferences during the pandemic and beyond Thale Jarvis, Shannon Weiman, Deborah Johnson
216 [GO] 2020―Sep―11 Molecular characterization of ebselen binding activity to SARS-CoV-2 main protease Cintia A. Menéndez, Fabian Byléhn, Gustavo R. Perez-Lemus, Walter Alvarado, Juan J. de Pablo
217 [GO] 2020―Sep―02 Continuous on-body sensing for the COVID-19 pandemic: Gaps and opportunities Hyoyoung Jeong, John A. Rogers, Shuai Xu
218 [GO] 2020―Aug―21 Efficient high-throughput SARS-CoV-2 testing to detect asymptomatic carriers Noam Shental, Shlomia Levy, Vered Wuvshet, Shosh Skorniakov, Bar Shalem, Aner Ottolenghi, et al. (+12)
219 [GO] 2020―Aug―14 Estimation of incubation period distribution of COVID-19 using disease onset forward time: A novel cross-sectional and forward follow-up study Jing Qin, Chong You, Qiushi Lin, Taojun Hu, Shicheng Yu, Xiao-Hua Zhou
220 [GO] 2020―Aug―05 Mandated Bacillus Calmette-Guérin (BCG) vaccination predicts flattened curves for the spread of COVID-19 Martha K. Berg, Qinggang Yu, Cristina E. Salvador, Irene Melani, Shinobu Kitayama
221 [GO] 2020―Jul―31 Acetylated K676 TGFBIp as a severity diagnostic blood biomarker for SARS-CoV-2 pneumonia Hee Ho Park, Hong Nam Kim, Hyelim Kim, Youngbum Yoo, Hyosoo Shin, Eun Young Choi, et al. (+2)
222 [GO] 2020―Jul―24 Non-neuronal expression of SARS-CoV-2 entry genes in the olfaory system suggests mechanisms underlying COVID-19-associated anosmia David H. Brann, Tatsuya Tsukahara, Caleb Weinreb, Marcela Lipovsek, Koen Van den Berge, Boying Gong, et al. (+19)
223 [GO] 2020―Jul―17 Cancer did not stay home for COVID-19 Ross L. Levine
224 [GO] 2020―Jun―24 Elusive consensus: Polarization in elite communication on the COVID-19 pandemic Jon Green, Jared Edgerton, Daniel Naftel, Kelsey Shoub, Skyler J. Cranmer
225 [GO] 2020―Jun―24 Structure-based drug designing and immunoinformatics approach for SARS-CoV-2 Pritam K. Panda, Murugan N. Arul, Paritosh Patel, Suresh K. Verma, Wei Luo, Horst-Günter Rubahn, et al. (+3)
226 [GO] 2020―Jun―12 Abrupt decline in tropospheric nitrogen dioxide over China after the outbreak of COVID-19 Fei Liu, Aaron Page, Sarah A. Strode, Yasuko Yoshida, Sungyeon Choi, Bo Zheng, et al. (+9)
227 [GO] 2020―Jun―12 Pandemics and the global environment Kip Hodges, Jeremy Jackson
228 [GO] 2020―Jun―05 Medical education in the time of COVID-19 Diane B. Wayne, Marianne Green, Eric G. Neilson
229 [GO] 2020―Mai―29 COVID-19 and the next influenza season Benjamin D. Singer
230 [GO] 2020―Mai―29 Emergence of SARS-CoV-2 through recombination and strong purifying selection Xiaojun Li, Elena E. Giorgi, Manukumar Honnayakanahalli Marichannegowda, Brian Foley, Chuan Xiao, Xiang-Peng Kong, et al. (+4)
231 [GO] 2020―Mai―22 SARS-CoV2 vaccines: Slow is fast Douglas R. Green
232 [GO] 2020―Mai―22 SARS-CoV2 vaccines: Slow is fast Douglas R. Green
233 [GO] 2020―Mai―18 Evidence for host-dependent RNA editing in the transcriptome of SARS-CoV-2 Salvatore Di Giorgio, Filippo Martignano, Maria Gabriella Torcia, Giorgio Mattiuz, Silvestro G. Conticello
234 [GO] 2020―Mai―11 COVID-19: Rescue by transcriptional inhibition Ali Shilatifard
235 [GO] 2020―Mai―07 Point of no return: COVID-19 and the US health care systemAn emergency physician’s perspective Maia Dorsett
236 [GO] 2020―Apr―27 Mobile phone data for informing public health actions across the COVID-19 pandemic life cycle Nuria Oliver, Bruno Lepri, Harald Sterly, Renaud Lambiotte, Sébastien Delataille, Marco De Nadai, et al. (+18)
237 [GO] 2020―Apr―17 Surviving COVID-19: A disease tolerance perspective Janelle S. Ayres
 [1] 

237 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.010 sec